Company / EPS (Diluted)
Processa Pharmaceuticals, Inc. EPS (Diluted) History
FY2013-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.54
FY2021
5-year range
-$2.54 / -$0.31
FY2017-FY2021
Trend
-719.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -719% YoY in FY2021, a notable deviation from the 4-year average annual change of -154%.
Based on SEC 10-K filings.
-2.54 in FY2021.
Declined from $-0.68 to $-2.54 over the past 6 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, eps (diluted) decreased 719.4% year-over-year.
- Peak eps (diluted) was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | -$2.54 | -719.4% |
| FY2016 | -$0.31 | +54.4% |
| FY2015 | -$0.68 | -11.5% |
| FY2014 | -$0.61 | +59.3% |
| FY2013 | -$1.50 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026